menu
    • menu

    Company profile for Cerus Corporation

    NEW Drugs in Dev: 9
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company, deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable product...
    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company, deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System, and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cerus CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1220 Concord Avenue Concord, CA US 94520
    Telephone
    Telephone
    +1 925.288.6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.cerus.com/Home/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cerus Corp Reveals 2025 Full-Year And Q4 Financials
    Cerus Corp Reveals 2025 Full-Year And Q4 Financials

    02 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260302840774/en/Cerus-Corporation-Announces-Full-Year-and-Fourth-Quarter-2025-Financial-Results

    BUSINESSWIRE
    02 Mar 2026
    Share Share
    Cerus to Release Q4, FY 2025 Results on March 2
    Cerus to Release Q4, FY 2025 Results on March 2

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217993418/en/Cerus-Corporation-to-Release-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-2-2026

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    DRK Launches INITIATE Study of INTERCEPT-Treated Platelets
    DRK Launches INITIATE Study of INTERCEPT-Treated Platelets

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260122198359/en/DRK-Blood-Donation-Service-Baden-Wrttemberg-Hessen-Starts-INITIATE-Study-to-Evaluate-Pathogen-Inactivated-Platelet-Concentrates-Treated-with-Cerus-INTERCEPT-Blood-System-in-Routine-Clinical-Practice

    BUSINESSWIRE
    22 Jan 2026
    Share Share
    Cerus Announces Q4 2025 Revenue, Outlook
    Cerus Announces Q4 2025 Revenue, Outlook

    11 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260111066393/en/Cerus-Corporation-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Product-Revenue-and-Provides-Outlook

    BUSINESSWIRE
    11 Jan 2026
    Share Share
    Cerus Announces IFC Abstracts & Workshop At 2025 AABB Meeting
    Cerus Announces IFC Abstracts & Workshop At 2025 AABB Meeting

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021249458/en/Cerus-Corporation-Announces-Abstracts-and-Industry-Workshop-on-IFC-at-the-2025-AABB-Annual-Meeting

    BUSINESSWIRE
    21 Oct 2025
    Share Share
    German Advisory Panel Recommends Safer Platelet Transfusions
    German Advisory Panel Recommends Safer Platelet Transfusions

    25 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825692652/en/The-German-National-Blood-Advisory-Committee-Issues-Formal-Recommendation-for-Improving-the-Safety-of-Platelet-Transfusions

    BUSINESSWIRE
    25 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search